What’s trending overseas

Published 24-JAN-2017 15:08 P.M.

|

2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

Uncertainty and fear of the unknown drove most post Inauguration Day markets, and this was evident last night in both the US and Europe with flat to negative performances from the Dow and the NASDAQ, and declines of approximately 0.6% in the FTSE 100, the Dax and the Paris CAC 40.

One of the most interesting moves was a significant strengthening of the Great Britain Pound against the US dollar, suggesting investors may feel a Brexit is more palatable than President Trump’s total exit strategy.

The focus has been intensifying on how Trump will actually execute on protectionist policies given the country’s reliance on the importation of cheaply manufactured goods to drive down the cost of living.

Imports from cheap manufacturing hubs in the broader Asian region are essential in terms of placing downward pressure on prices and keeping everything from household items to consumer discretionary products such as mobile phones and televisions within the reach of the average American.

While tax cuts will increase net income, the jury is out as to whether they can compensate for considerably higher consumer spending on goods that were traditionally sourced from overseas, but under the new regime, would be manufactured at a much higher cost in the US.

In the wake of the inauguration it was White House Press Secretary Sean Spicer who was the first casualty. A little like being corrected on the first day of school for not being able to count, in his first official briefing he released inauguration crowd figures that were clearly ‘trumpaganda’, and he was subsequently slammed by the media.

Looking at the more tangible, on the commodities front, gold spiked from the previous day’s close of US$1204 per ounce to hit a high of US$1219 per ounce, perhaps evidence of a shift towards safe haven investments.

While there was little movement in nickel and copper, a strong performance by zinc resulted in it pushing up towards record December levels before retracing late in the session.

As is often the case, lead followed suit, increasing from the previous day’s close of US$1.05 per pound to US$1.075 per pound. Declining warehouse stocks of both zinc and lead tend to suggest the rally has legs.

Iron ore was slightly stronger, while oil gave up some of the previous trading session’s gains to finish at US$52.80 per barrel.

As markets drew to a close in the US, the Australian dollar was fetching US$0.757.

It should be noted that broker projections and price targets are only estimates and may not be met. Also, historical data in terms of earnings performance and/or share trading patterns should not be used as the basis for an investment as they may or may not be replicated. Those considering this stock should seek independent financial advice.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X